These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23808708)

  • 41. Calcium channel blockers' contribution to overcoming Current drug discovery challenges in Alzheimer's disease.
    Bernard PJ; Bellili D; Ismaili L
    Expert Opin Drug Discov; 2024; 19(1):21-32. PubMed ID: 37800853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus.
    Hanyu H; Sato T; Kiuchi A; Sakurai H; Iwamoto T
    J Am Geriatr Soc; 2009 Jan; 57(1):177-9. PubMed ID: 19170800
    [No Abstract]   [Full Text] [Related]  

  • 44. New and emerging drug treatments for hypertension.
    Krum H; Pellizzer AM
    Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.
    Maciejewska K; Czarnecka K; Szymański P
    Pharmacol Rep; 2021 Dec; 73(6):1565-1581. PubMed ID: 34121170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focusing on the Link between Diabetes, Alzheimer's Disease and Cancer for the Discovery of New Medicines.
    Yang X; Wang K
    Curr Top Med Chem; 2016; 16(7):675-6. PubMed ID: 26381416
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.
    Corbett A; Williams G; Ballard C
    Pharmaceuticals (Basel); 2013 Oct; 6(10):1304-21. PubMed ID: 24275851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological approach for drug repositioning against cardiorenal diseases.
    Zamami Y; Imanishi M; Takechi K; Ishizawa K
    J Med Invest; 2017; 64(3.4):197-201. PubMed ID: 28954981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tackling Alzheimer's Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles.
    Rampa A; Gobbi S; Belluti F; Bisi A
    Curr Med Chem; 2021; 28(12):2305-2327. PubMed ID: 32867634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interview with Farid Khan, PhD.
    Assay Drug Dev Technol; 2016 Dec; 14(10):551-553. PubMed ID: 27922743
    [No Abstract]   [Full Text] [Related]  

  • 51. The Potential of Genetic Data for Prioritizing Drug Repurposing Efforts.
    Gill D; Vujkovic M
    Neurology; 2022 Aug; 99(7):267-268. PubMed ID: 35654591
    [No Abstract]   [Full Text] [Related]  

  • 52. Editorial: The dawn of a new era of Alzheimer's research and drug development.
    Hara Y; Fillit HM
    J Prev Alzheimers Dis; 2022; 9(3):385-386. PubMed ID: 35841237
    [No Abstract]   [Full Text] [Related]  

  • 53. Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments.
    Sales TA; Prandi IG; Castro AA; Leal DHS; Cunha EFFD; Kuca K; Ramalho TC
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.
    Qosa H; Mohamed LA; Al Rihani SB; Batarseh YS; Duong QV; Keller JN; Kaddoumi A
    J Alzheimers Dis; 2016 Jul; 53(4):1499-516. PubMed ID: 27392852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.
    Kasza Á; Hunya Á; Frank Z; Fülöp F; Török Z; Balogh G; Sántha M; Bálind Á; Bernáth S; Blundell KL; Prodromou C; Horváth I; Zeiler HJ; Hooper PL; Vigh L; Penke B
    J Alzheimers Dis; 2016 May; 53(2):557-71. PubMed ID: 27163800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?
    Corbett A; Ballard C
    Expert Opin Investig Drugs; 2013 Aug; 22(8):941-3. PubMed ID: 23808708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review: treatment of Alzheimer's disease discovered in repurposed agents.
    Appleby BS; Nacopoulos D; Milano N; Zhong K; Cummings JL
    Dement Geriatr Cogn Disord; 2013; 35(1-2):1-22. PubMed ID: 23307039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medical genetics-based drug repurposing for Alzheimer's disease.
    Zhang XZ; Quan Y; Tang GY
    Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug repositioning in Alzheimer's disease.
    Corbett A; Williams G; Ballard C
    Front Biosci (Schol Ed); 2015 Jun; 7(1):184-8. PubMed ID: 25961694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.
    Lee H; Kim E
    Arch Pharm Res; 2020 Sep; 43(9):932-960. PubMed ID: 32909178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.